BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 29, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 15, 2020

View Archived Issues
Coronavirus-paper-dolls

Mass fever scanner could reduce spread of COVID-19

As state and federal authorities deliberate over how to safely reopen U.S. society during the ongoing COVID-19 pandemic, tools that effectively monitor body temperature at a population level could help to get the ball rolling. To that end, software development firm Altoros Inc., of Sunnyvale, Calif., has released the Fever Screener, a fully automated, enterprise-grade system for setting up temperature scanning checkpoints. Fever Screener can scan up to 30 people simultaneously at a distance of 3 meters, or nearly 10 feet, with a temperature accuracy of roughly 0.6 degrees Fahrenheit. Installed in entryways, checkpoints or other crowded venues, it can provide mass screenings, as well as recurrent temperature monitoring for potentially infected individuals. Read More
business-performance-pipeline.png

J&J beats Wall Street expectations for Q1, but medical devices hit hard by COVID-19

Johnson & Johnson (J&J) managed to beat analyst earnings estimates due to unexpectedly strong first-quarter results in its consumer health and pharmaceutical businesses. But while those saw revenues climb in the double digits, its medical devices business declined by almost 5% due to deferred procedures. Wall Street rewarded the New Brunswick, N.J.-based company by driving its shares (NYSE:JNJ) up more than 5%. That’s even though the company also lowered its 2020 guidance. Read More
WHO-headquarters

EU leaders pan Trump’s move to halt U.S. funding as WHO updates COVID-19 response plan

LONDON - The director general of the World Health Organization has given a dignified and measured response to President Donald Trump’s decision to halt U.S. funding of WHO, pending a review of its handling of the coronavirus pandemic. Read More
respiratory-lung-COVID-19-coronavirus.png

FDA’s Stenzel: EUA for COVID-19 home collection sample kit will happen ‘very soon’

An April 15 U.S. FDA stakeholder call revisited several themes of interest in connection with diagnostics for the COVID-19 pandemic. However, Tim Stenzel, director of the agency’s Office of In Vitro Diagnostics and Radiological Health, said that while the agency has not yet authorized a home sample collection kit, “we do think it’s going to happen very soon.” Read More
CAE-group-ventilator.png

CAE retools mannequin medical simulator to build ventilators in COVID-19 fight

Within two weeks of a public challenge to design user-friendly, easily built ventilators, Montreal-based CAE Inc., formerly Canadian Aviation Electronics, began gearing up to distribute 10,000 units of its newly created ventilator over the next three months. Read More
cochlear-remote-check.png

Amid COVID-19 uncertainty and patent battle loss, Cochlear raises AU$880M, rolls out remote solution

PERTH, Australia – Cochlear Ltd., of Sydney, is gearing up to launch its new Remote Check solution for cochlear implant users on the heels of an AU$880 million (US$559 million) capital raise and a patent battle loss that it plans to appeal. Read More

Appointments and advancements for April 15, 2020

New hires and promotions in the med-tech industry, including: Advarra, Leo Lens Pharma, Precision Biosciences. Read More

Financings for April 15, 2020

Med-tech firms raising money in public or private financings, including: Vida Diagnostics. Read More

In the clinic for April 15, 2020

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytosorbents, Nanostring, Pathnostics. Read More

Other news to note for April 15, 2020

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1Health.io, 3M, Abbott Laboratories, Axovant Gene Therapies, Babson Diagnostics, Biological Specialty, Centogene, Cohealo, Envisiontec, Essence Group, Eyenuk, GE Healthcare, Healthspace, IDT, Invitae, Nag, Prenetics, Provecs Medical, Prudential, Xcelom, Promis Neurosciences, Neurocode, UBC Diagnostic Services, Q-Centrix, Shadowbox, Sygnature, Todos Medical, Uchimura Robotics, UVD Robots. Read More

Regulatory actions for April 15, 2020

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Behold.ai, Chembio, Nova Biomedical, Ortho. Read More

Regulatory front for April 15, 2020

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Advamed, Cardinal Health, Face Vital, Thermo Fisher Scientific. Read More

BioWorld MedTech’s Orthopedics Extra for April 15, 2020

Keeping you up to date on recent developments in orthopedics, including: Researchers develop synthetic scaffolds to heal injured tendons, ligaments; Self-powered X-ray detector to revolutionize imaging for medicine, security and research; Opioid prescriptions linked to obesity. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 27, 2026.
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Vials, syringes, and pills

    With improved technologies, biomarkers, failed drugs may come into their own

    BioWorld
    At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing